$31.09
0.110.36%
Last update: Oct 26, 3:01 PM
Immunocore Holdings PLC (IMCR) Stock Price, Quote, News & History
IMCRNASDAQ
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
You can purchase shares of Immunocore Holdings (NASDAQ:IMCR) through any online brokerage.
Other companies in Immunocore Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Immunocore Holdings has a consensus price target of $63.63.
The stock price for Immunocore Holdings (NASDAQ: IMCR) is $31.09 last updated October 26, 2026 at 3:01 PM EDT.
There are no upcoming dividends for Immunocore Holdings.
Immunocore Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Immunocore Holdings.
Immunocore Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease,...
